1. Treatment of Malignant Pleural Effusion: A Cost-Effectiveness Analysis
Varun Puri, MD, Tanya L. Pyrdeck, RHIT, Traves D. Crabtree, MD, Daniel Kreisel, MD, PhD, Alexander S. Krupnick, MD, Graham A. Colditz, DrPH, G. Alexander Patterson, MD, Bryan F. Meyers, MD 
The Annals of Thoracic Surgery 
Volume 94, Issue 2, Pages (August 2012)
DOI: /j.athoracsur
Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

2. Fig 1
Results of a 2-way sensitivity analysis varying the rate of complications with tunneled pleural catheter and risk of recurrence with bedside pleurodesis. It identifies which strategy is optimal in regions of values of the variables; thresholds are simply the border between two regions. As an example, if the rate of complications with TPC is 16%, BP would be the preferred option if rate of recurrence of effusion with BP is less than 33%. (TPC_compl = rate of complication with tunneled pleural catheter [expressed as a fraction]; BP_recurrent = rate of recurrence with bedside pleurodesis [expressed as a fraction]; wtp = willingness to pay set at $50,000/additional QALY gained.)
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions